Statistics for Platelet-Activating Factor-Receptor and Tumor Immunity
Total visits
views | |
---|---|
Platelet-Activating Factor-Receptor and Tumor Immunity | 171 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
nihms784249.pdf | 89 |
java.util.UUID:a30d9a52-2b47-49bf-b19b-87bafb8ee782 | 42 |
java.util.UUID:c06d4586-54f4-4912-83d1-4a9e88bab93d | 8 |
java.util.UUID:62a83d40-24a4-4359-a004-e0ba25feecfe | 3 |
Top country views
views | |
---|---|
United States | 111 |
Germany | 15 |
Ukraine | 7 |
Russia | 5 |
China | 3 |
Canada | 2 |
France | 2 |
United Kingdom | 2 |
Brazil | 1 |
Czechia | 1 |
Malaysia | 1 |
Sweden | 1 |
Top city views
views | |
---|---|
Wilmington | 46 |
Ann Arbor | 17 |
Kiez | 14 |
White Plains | 8 |
Jacksonville | 7 |
Kiev | 7 |
Houston | 6 |
Dearborn | 4 |
Saint Petersburg | 4 |
Fairfield | 3 |
San Francisco | 3 |
Washington | 3 |
Beijing | 2 |
Cambridge | 2 |
Concord | 2 |
Toronto | 2 |
Abingdon | 1 |
Araçuaí | 1 |
Baltimore | 1 |
Brooklyn | 1 |
Gunzenhausen | 1 |
Laurel | 1 |
Moscow | 1 |
Paris | 1 |
Philadelphia | 1 |
Roubaix | 1 |
Seremban | 1 |
Slapanice | 1 |
Stockholm | 1 |
Wuhan | 1 |